IDEAYA Biosciences, Inc. Common Stock

IDYANASDAQ • USD
ThemeHealthcare - Oncology›Targeted Therapy & Precision Oncology
28.29 USD
↘ 0.93 (3.18%)AT CLOSE (11:59 AM EDT)
27.27
↘ 1.02 (3.61%)
POST MARKET (AS OF 06:41 PM EDT)
Post Market
AS OF 06:41 PM EDT
27.27
↘ 1.02 (3.61%)
🔴Market: CLOSED
Open?$29.22
High?$29.60
Low?$28.19
Prev. Close?$29.22
Volume?710.9K
Avg. Volume?831.3K
VWAP?$28.67
Rel. Volume?0.86x
Bid / Ask
Bid?$24.26 × 100
Ask?$32.20 × 100
Spread?$7.94
Midpoint?$28.23
Valuation & Ratios
Market Cap?2.6B
Shares Out?87.9M
Float?87.1M
Float %?99.1%
P/E Ratio?N/A
P/B Ratio?2.74
EPS?-$1.59
Dividend?0.00%
Ex-Dividend?N/A

IDYA is currently priced at $28.30. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On valuation, IDYA trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.
Themes
Healthcare - Oncology›Targeted Therapy & Precision OncologyHealthcare - Genomics & Precision Medicine›Precision Medicine Platforms
Employees
145
Market Cap
2.5B
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.ideayabio.com
Listed
2019-05-23
Address
5000 SHORELINE CT, SUITE 300
SOUTH SAN FRANCISCO, CA 94080
Phone: 650-443-6209
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
9
Short Sent.?
28
Piotroski F-Score?0/9Weak
Altman Z-Score?15.78Safe
Confidence?49%Low
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?13.44%High
Short Interest?11.7M
Days to Cover?14.0
Free Float87.1M
Avg Daily Volume838.5K
Settlement Date2026-05-15
Financial Health
Current Ratio?10.74Strong
Quick Ratio?10.74Strong
Cash Ratio?2.43Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
60
2.74CHEAP▾
P/S?
Peers
100
S&P
6
11.40HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-13.3CHEAP▾
EV/Sales?
Peers
100
S&P
9
10.70HIGH▾
Returns & Efficiency
ROE?
S&P
9
-14.9%WEAK▾
ROA?
S&P
3
-13.6%WEAK▾
Cash Flow & Enterprise
FCF?$-87931000
Enterprise Value?$2.4B
Fundamentals ratios updated end of day
MarketsMoversWatchlist